ENG

Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals

News

Bird & Bird named most active clean energy legal adviser in the Clean Energy League Table 2025

May 19 2025

Read More

Deal

Bird & Bird Advises Voyc on $2 Million Seed Funding Round

May 14 2025

Read More

Deal

Bird & Bird advises Contour Design on acquisition of Active Key business from Cherry SE

May 13 2025

Read More

Deal

Bird & Bird advised Entegra on the acquisition of Agap’pro

May 13 2025

Read More

Deal

Bird & Bird advises Vanagon Ventures on seed investment in Particula

May 07 2025

Read More

Deal

Bird & Bird advises BRIDOR on its global bakery transaction in Australia

May 07 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare
OSZAR »